Surgical Science Sweden AB (publ) (STO:SUS)

Market Cap	1.23B -86.0%
Revenue (ttm)	975.04M +13.4%
Net Income	69.83M -63.9%
EPS	1.37 -63.9%
Shares Out	51.03M
PE Ratio	17.67
Forward PE	11.50
Dividend	n/a
Ex-Dividend Date	n/a

Volume	234,509
Average Volume	385,875
Open	25.68
Previous Close	24.18
Day's Range	24.28 - 25.68
52-Week Range	23.70 - 192.40
Beta	0.52
RSI	27.31
Earnings Date	Feb 19, 2026

About STO:SUS

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy tra...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 328
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SUS

Financial Performance

In 2024, STO:SUS's revenue was 884.09 million, an increase of 0.14% compared to the previous year's 882.85 million. Earnings were 131.65 million, a decrease of -43.73%.